Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited To Report Fourth Quarter and Fiscal Year 2014 Financial Results and Host Conference Call View HTML
Toggle Summary Quotient Limited Prices Initial Public Offering View HTML
Toggle Summary Evaluation of the MosaiQ™ Platform Chosen as a Top Poster at the AABB 2013 Annual Meeting View HTML
Toggle Summary Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners View HTML
Toggle Summary Quotient Biodiagnostics Signs 36 Month Laboratory Solutions Agreement With Amerinet Inc. to Supply Blood Bank Reagents to Member Hospitals View HTML
Toggle Summary Quotient Receives FDA License to Sell a Range of Rare Polyclonal Antisera Products in the USA View HTML
Toggle Summary Quotient Biodiagnostics Signs 36-month Agreement with the Premier Health Alliance to Supply Blood Bank Reagents to its 2,600 Member Hospitals View HTML
Toggle Summary Quotient Biodiagnostics Raises $11.2 Million of Growth Finance Led by Galen Partners View HTML
Toggle Summary Quotient Receives FDA License to Sell a Full Range of Reagent Red Blood Cell Products View HTML
Toggle Summary Quotient Biodiagnostics Wins 5-Year Award to Supply Blood Bank Reagents to the U.S. Government View HTML